We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
-9.93%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
10 Year Est. Return
AUM
$214M
AUM Growth
-$73.6M
Cap. Flow
-$47.3M
Cap. Flow %
-22.15%
Top 10 Hldgs %
55.28%
Holding
36
New
Increased
5
Reduced
19
Closed
8

Top Sells

Rank Stock Value
1
WCC
WESCO International
WCC
+$10.3M
2
MCK icon
McKesson
MCK
+$8.85M
3
LMT icon
Lockheed Martin
LMT
+$8.65M
4
MTH icon
Meritage Homes
MTH
+$7.69M
5
LEN icon
Lennar Class A
LEN
+$5.59M

Sector Composition

Rank Sector Weight
1 Healthcare 21.61%
2 Energy 20.63%
3 Technology 14%
4 Industrials 11.09%
5 Consumer Discretionary 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MS icon
26
Morgan Stanley
MS
$339B
$822K 0.38%
10,805
EPD icon
27
Enterprise Products Partners
EPD
$82.6B
$606K 0.28%
24,855
RUSHB icon
28
Rush Enterprises Class B
RUSHB
$5.89B
$323K 0.15%
9,761
LEN icon
29
Lennar Class A
LEN
$20.2B
-71,139
Closed -$5.59M
LMT icon
30
Lockheed Martin
LMT
$117B
-19,605
Closed -$8.65M
MTH icon
31
Meritage Homes
MTH
$4.95B
-194,228
Closed -$7.69M
PKW icon
32
Invesco BuyBack Achievers ETF
PKW
$1.69B
-5,699
Closed -$516K
SPIP icon
33
State Street SPDR Portfolio TIPS ETF
SPIP
$1,000M
-7,797
Closed -$236K
WCC
34
WESCO International
WCC
$16B
-78,911
Closed -$10.3M
EQC
35
DELISTED
Equity Commonwealth
EQC
-113,328
Closed -$3.2M
LYLT
36
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
-50,047
Closed -$827K

Similar funds

Muhlenkamp & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Muhlenkamp & Co held 36 positions worth $214M, down 26% from $287M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Muhlenkamp & Co withdrew a net $47.3M in Q2 2022, closing 8 positions and reducing 19 holdings. Its most notable exit was WESCO International, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 19% a quarter earlier, followed by Energy and Technology.

Against the trend, Muhlenkamp & Co added an estimated $49.5K to Bristol-Myers Squibb.

  • Muhlenkamp & Co added most to Bristol-Myers Squibb in Q2 2022, an estimated $49.5K increase.
  • Muhlenkamp & Co's biggest Q2 2022 reduction was McKesson, cutting an estimated $8.85M.
  • Muhlenkamp & Co fully exited WESCO International in Q2 2022, selling an estimated $10.3M.
  • Muhlenkamp & Co's ten largest holdings make up 55% of its $214M portfolio in Q2 2022.
  • Muhlenkamp & Co opened 0 new positions and closed 8 in Q2 2022.
  • Muhlenkamp & Co's portfolio value fell 26% quarter-over-quarter to $214M.

Based on Muhlenkamp & Co's 13F filing for Q2 2022, filed 18 Jul 2022.